A prospective evaluation of the outcome after small saphenous varicose vein surgery with one-year follow-up

O’Hare, J.; Vandenbroeck, C.P.; Whitman, Birgit; Campbell, Bruce; Heather, B. P.; Earnshaw, J. J.

doi:10.1016/j.jvs.2008.04.041

Cited by 52 publications

(45 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In one recent prospective multicentre observational study paraesthesia was present in 27 per cent of legs at 6 weeks, and in the majority this persisted after 12 months 3 . Two studies reported visible recurrent varicose veins in 26 and 30 per cent of patients at 1 and 5 years respectively 3,6 .…”

Section: Discussionmentioning

confidence: 99%

“…By contrast, the literature indicates that outcomes after surgery for SSV are often suboptimal, with high rates of recurrence and a significant complication rate 2 -9 . Popliteal fossa anatomy is highly variable and, despite preoperative duplex marking, surgery is often technically inadequate, with an intact SPJ being reported in 24-47 per cent of patients at 6 weeks 3,5,8 . In one recent prospective multicentre observational study paraesthesia was present in 27 per cent of legs at 6 weeks, and in the majority this persisted after 12 months 3 .…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Medium-term results of ultrasound-guided foam sclerotherapy for small saphenous varicose veins

Darvall

Bate

Silverman

et al. 2009

British Journal of Surgery

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Medium-term results of ultrasound-guided foam sclerotherapy for small saphenous varicose veins

Darvall

Bate

Silverman

et al. 2009

British Journal of Surgery

View full text Add to dashboard Cite

show abstract

“…Although it has been suggested that femoral and popliteal vein incompetency regresses after the management of saphenous incompetency, 4,12,13,[22][23][24] the fate of an incompetent GCV is unknown. 12) In the early three cases and the great saphenous vein case, the incompetency of the GCV did not improve after saphenous vein surgery.…”

Section: Discussionmentioning

confidence: 99%

The Incidence, Clinical Importance and Management of Incompetent Gastrocnemius Vein

Nakayama¹

2016

Annals of Vascular Diseases

View full text Add to dashboard Cite

“…However, sural nerve injury is still considered a major and potentially underreported complication [25, 26]. Due to the fact that no heat and tumescent is used in MOCA™, nerve injury after SSV ablation might become a redundant complication.…”

Section: Discussionmentioning

confidence: 99%

Mechanochemical endovenous ablation versus radiofrequency ablation in the treatment of primary small saphenous vein insufficiency (MESSI trial): study protocol for a randomized controlled trial

Boersma

Eekeren

Kelder

et al. 2014

Trials

View full text Add to dashboard Cite

BackgroundMinimally invasive endothermal techniques, for example, radiofrequency ablation (RFA), have revolutionized the treatment of insufficient truncal veins and are associated with an excellent outcome. The use of thermal energy requires the instillation of tumescent anesthesia around the vein. Mechanochemical endovenous ablation (MOCA™) combines mechanical endothelial damage, using a rotating wire, with simultaneous infusion of a liquid sclerosans. Tumescent anesthesia is not required as no heat is used. Prospective studies using MOCA™ in both great and small saphenous veins showed good anatomical and clinical results with fast postoperative recovery.Methods/DesignThe MESSI trial (Mechanochemical Endovenous ablation versus radiofrequency ablation in the treatment of primary Small Saphenous vein Insufficiency) is a multicenter randomized controlled trial in which a total of 160 patients will be randomized (1:1) to MOCA™ or RFA. Consecutive patients with primary small saphenous vein incompetence, who meet the eligibility criteria, will be invited to participate in this trial. The primary endpoint is anatomic success, defined as occlusion of the treated veins objectified with duplex ultrasonography at 1 year follow-up. Secondary endpoints are post-procedural pain, initial technical success, clinical success, complications and the duration of the procedure. Initial technical success is defined as the ability to position the device adequately, treat the veins as planned and occlude the treated vein directly after the procedure has been proven by duplex ultrasonography. Clinical success is defined as an objective improvement of clinical outcome after treatment, measured with the Venous Clinical Severity Score (VCSS). Power analyses are conducted for anatomical success and post-procedural pain.Both groups will be evaluated on an intention-to-treat principle.DiscussionThe hypothesis of the MESSI trial is that the anatomic success rate of MOCA™ is not inferior to RFA. The second hypothesis is that post-procedural pain is significantly less after MOCA compared to RFA.Trial registrationTrial registration: NTR4613 Date of trial registration: 28 May 2014.

show abstract

A prospective evaluation of the outcome after small saphenous varicose vein surgery with one-year follow-up

Abstract: Stripping of the SSV significantly reduced the rate of SPJ incompetence after one year without increasing the rate of complications.

Cited by 52 publications

References 21 publications

Medium-term results of ultrasound-guided foam sclerotherapy for small saphenous varicose veins

Medium-term results of ultrasound-guided foam sclerotherapy for small saphenous varicose veins

The Incidence, Clinical Importance and Management of Incompetent Gastrocnemius Vein

Mechanochemical endovenous ablation versus radiofrequency ablation in the treatment of primary small saphenous vein insufficiency (MESSI trial): study protocol for a randomized controlled trial

Contact Info

Product

Resources

About